Improving culture of care through maximising learning from observations and events: Addressing what is at fault.

Care animal facilities welfare

Journal

Laboratory animals
ISSN: 1758-1117
Titre abrégé: Lab Anim
Pays: England
ID NLM: 0112725

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 9 9 2021
medline: 10 5 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

The term 'culture of care' in the context of using animals for scientific purpose describes the culture in organisations that provides support to staff to strive for continuous improvement in:• animal care and welfare;• support and recognition of staff involved in the animal care and use programme;• scientific quality;• openness and transparency.We developed a systematic process for reporting observations and events that have the potential to help with continuous learning, improving animal welfare and supporting staff. The process took learning from the safety, health and environment arena on accident prevention. The two key aspects were (a) the systematic logging of observations and events; and (b) the learning approach to following up on observations. Underpinning our systematic process is the 'Learning from Observations and Events Log'. Reported observations and events can relate to positive practices, general observations as well as near misses.We created an environment to promote continuous improvement for both animals and staff by recognising, rewarding and sharing good practice, as well as where near misses are openly reported and learnt from. Supporting animal welfare, staff welfare, improving scientific quality and transparency are the four key pillars of a positive culture of care.We recognised early on that using a system and learning approach to follow up on observations and events rather than a people and blame approach was key to developing open reporting and a positive culture. In the systems approach, errors are consequences rather than causes, having their origins in systemic factors.

Identifiants

pubmed: 34494470
doi: 10.1177/00236772211037177
pmc: PMC9082962
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-146

Références

BMJ. 2000 Mar 18;320(7237):768-70
pubmed: 10720363
Vet Rec. 2015 Oct 31;177(17):438
pubmed: 26489997
Lab Anim. 2019 Nov 19;:23677219887998
pubmed: 31744380

Auteurs

Sally Robinson (S)

Animal Sciences and Technologies, AstraZeneca, UK.

Wesley White (W)

Global Engineering and Real Estate, AstraZeneca, UK.

John Wilkes (J)

Global Pharmaceutical Quality System, AstraZeneca, USA.

Catherine Wilkinson (C)

Animal Sciences and Technologies, AstraZeneca, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH